Vertex Pharmaceuticals (VRTX) Intangibles (2016 - 2025)
Historic Intangibles for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $424.2 million.
- Vertex Pharmaceuticals' Intangibles fell 4863.78% to $424.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $424.2 million, marking a year-over-year decrease of 4863.78%. This contributed to the annual value of $424.2 million for FY2025, which is 4863.78% down from last year.
- According to the latest figures from Q4 2025, Vertex Pharmaceuticals' Intangibles is $424.2 million, which was down 4863.78% from $429.8 million recorded in Q3 2025.
- In the past 5 years, Vertex Pharmaceuticals' Intangibles ranged from a high of $839.9 million in Q4 2023 and a low of $387.0 million during Q2 2022
- In the last 5 years, Vertex Pharmaceuticals' Intangibles had a median value of $522.4 million in 2022 and averaged $565.3 million.
- Its Intangibles has fluctuated over the past 5 years, first surged by 5596.9% in 2023, then plummeted by 4863.78% in 2025.
- Over the past 5 years, Vertex Pharmaceuticals' Intangibles (Quarter) stood at $400.0 million in 2021, then skyrocketed by 50.9% to $603.6 million in 2022, then soared by 39.15% to $839.9 million in 2023, then dropped by 1.67% to $825.9 million in 2024, then crashed by 48.64% to $424.2 million in 2025.
- Its Intangibles stands at $424.2 million for Q4 2025, versus $429.8 million for Q3 2025 and $435.5 million for Q2 2025.